Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?
Not Applicable
Completed
- Conditions
- Pancreatic Ductal Adenocarcinoma
- Interventions
- Procedure: Pancreaticoduodenectomy with Extended lymphadenectomyProcedure: Pancreaticoduodenectomy with Standard lymphadenectomy
- First Posted Date
- 2016-06-01
- Last Posted Date
- 2021-11-23
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 230
- Registration Number
- NCT02787187
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Chidamide Plus Chemotherapy in the Treatment of Peripheral T-cell Lymphoma
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 33
- Registration Number
- NCT02753543
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Chidamide Plus R-CHOP in Elderly DLBCL
Phase 2
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- First Posted Date
- 2016-04-28
- Last Posted Date
- 2017-11-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 49
- Registration Number
- NCT02753647
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Reduced Chemotherapy in Low Risk DLBCL
Phase 4
Active, not recruiting
- Conditions
- Diffuse Large B-cell Lymphoma
- Interventions
- First Posted Date
- 2016-04-27
- Last Posted Date
- 2022-12-05
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 290
- Registration Number
- NCT02752815
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
The Relationship Between Cerebral State and Emotion in Anesthesiologist and Surgeon
Completed
- Conditions
- Burnout, Professional
- First Posted Date
- 2016-03-25
- Last Posted Date
- 2016-03-25
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 40
- Registration Number
- NCT02719080
- Locations
- 🇨🇳
Department of Anesthesiology, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, Shanghai, China
Intravitreal Ranibizumab Injection as Adjuvant in the Treatment of Postvitrectomy Diabetic Vitreous Hemorrhage Accompanied by Neovascular Glaucoma
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2016-01-06
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 18
- Registration Number
- NCT02647515
MESA Versus ESA in the Treatment of Early Stage NK/T-cell Lymphoma
Phase 3
- Conditions
- Extranodal NK/T-cell Lymphoma, Nasal Type
- Interventions
- First Posted Date
- 2015-12-16
- Last Posted Date
- 2021-08-25
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 256
- Registration Number
- NCT02631239
- Locations
- 🇨🇳
Ruijin Hospital, Shanghai, Shanghai, China
Exposure and Response Prevention Therapy for Obsessive-compulsive Disorder
Not Applicable
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Behavioral: Exposure and Response Prevention Therapy
- First Posted Date
- 2015-11-11
- Last Posted Date
- 2016-11-29
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 48
- Registration Number
- NCT02602886
- Locations
- 🇨🇳
West China Hospital, Chengdu, Sichuan, China
🇨🇳Shanghai Hongkou Mental Health Center, Shanghai Shi, China
🇨🇳Suzhou Guangji Hospital, Suzhou, China
Novel Deep Brain Stimulation in Ventral Capsule and Stratum for Refractory Obsessive-Compulsive Disorder
Phase 2
- Conditions
- Obsessive-Compulsive Disorder
- Interventions
- Device: deep brain stimulation system
- First Posted Date
- 2015-10-29
- Last Posted Date
- 2016-12-06
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 8
- Registration Number
- NCT02590445
- Locations
- 🇨🇳
Shanghai Ruijin Hospital, Shanghai, Shanghai, China
Maintenance Treatment With Capecitabine Metronomic Chemotherapy and Chinese Traditional Medicine in Metastatic Colorectal Cancer
Phase 4
- Conditions
- Metastatic Colorectal Cancer
- Interventions
- Drug: Metronimic chemotherapyDrug: Metronimic chemotherapy plus Chinese Traditional Medicine
- First Posted Date
- 2015-10-14
- Last Posted Date
- 2015-10-14
- Lead Sponsor
- Ruijin Hospital
- Target Recruit Count
- 159
- Registration Number
- NCT02575378
© Copyright 2025. All Rights Reserved by MedPath